209 related articles for article (PubMed ID: 7702190)
1. Membrane partition coefficients chromatographically measured using immobilized artificial membrane surfaces.
Ong S; Liu H; Qiu X; Bhat G; Pidgeon C
Anal Chem; 1995 Feb; 67(4):755-62. PubMed ID: 7702190
[TBL] [Abstract][Full Text] [Related]
2. Immobilized-artificial-membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability.
Ong S; Liu H; Pidgeon C
J Chromatogr A; 1996 Mar; 728(1-2):113-28. PubMed ID: 8673230
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamics of solute partitioning into immobilized artificial membranes.
Ong S; Pidgeon C
Anal Chem; 1995 Jul; 67(13):2119-28. PubMed ID: 8694249
[TBL] [Abstract][Full Text] [Related]
4. Predicting drug-membrane interactions by HPLC: structural requirements of chromatographic surfaces.
Liu H; Ong S; Glunz L; Pidgeon C
Anal Chem; 1995 Oct; 67(19):3550-7. PubMed ID: 8686902
[TBL] [Abstract][Full Text] [Related]
5. Molecular factors influencing retention on immobilized artifical membranes (IAM) compared to partitioning in liposomes and n-octanol.
Taillardat-Bertschinger A; Martinet CA; Carrupt PA; Reist M; Caron G; Fruttero R; Testa B
Pharm Res; 2002 Jun; 19(6):729-37. PubMed ID: 12134941
[TBL] [Abstract][Full Text] [Related]
6. Characterization of immobilized artificial membrane (IAM) and XTerra columns by means of chromatographic models.
Lázaro E; Ràfols C; Rosés M
J Chromatogr A; 2005 Jul; 1081(2):163-73. PubMed ID: 16038206
[TBL] [Abstract][Full Text] [Related]
7. Immobilized artificial membrane (IAM)-HPLC for partition studies of neutral and ionized acids and bases in comparison with the liposomal partition system.
Ottiger C; Wunderli-Allenspach H
Pharm Res; 1999 May; 16(5):643-50. PubMed ID: 10350005
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Caldwell GW; Masucci JA; Evangelisto M; White R
J Chromatogr A; 1998 Mar; 800(2):161-9. PubMed ID: 9561760
[TBL] [Abstract][Full Text] [Related]
9. Prediction of drug-membrane interactions by IAM-HPLC: effects of different phospholipid stationary phases on the partition of bases.
Barbato F; di Martino G; Grumetto L; La Rotonda MI
Eur J Pharm Sci; 2004 Jul; 22(4):261-9. PubMed ID: 15196582
[TBL] [Abstract][Full Text] [Related]
10. Hydrophobicity of HIV protease inhibitors by immobilized artificial membrane chromatography: application and significance to drug transport.
Stewart BH; Chung FY; Tait B; Blankley CJ; Chan OH
Pharm Res; 1998 Sep; 15(9):1401-6. PubMed ID: 9755892
[TBL] [Abstract][Full Text] [Related]
11. Prediction of oral absorption in humans by experimental immobilized artificial membrane chromatography indices and physicochemical descriptors.
Kotecha J; Shah S; Rathod I; Subbaiah G
Int J Pharm; 2008 Aug; 360(1-2):96-106. PubMed ID: 18524510
[TBL] [Abstract][Full Text] [Related]
12. Preparation of mixed ligand immobilized artificial membranes for predicting drug binding to membranes.
Pidgeon C; Ong S; Choi H; Liu H
Anal Chem; 1994 Sep; 66(17):2701-9. PubMed ID: 7943735
[TBL] [Abstract][Full Text] [Related]
13. Chromatographic estimation of drug disposition properties by means of immobilized artificial membranes (IAM) and C18 columns.
Lázaro E; Ràfols C; Abraham MH; Rosés M
J Med Chem; 2006 Aug; 49(16):4861-70. PubMed ID: 16884298
[TBL] [Abstract][Full Text] [Related]
14. Lecithin liposomes and microemulsions as new chromatographic phases.
Amézqueta S; Fernández-Pumarega A; Farré S; Luna D; Fuguet E; Rosés M
J Chromatogr A; 2020 Jan; 1611():460596. PubMed ID: 31610920
[TBL] [Abstract][Full Text] [Related]
15. The use of biopartitioning micellar chromatography and immobilized artificial membrane column for in silico and in vitro determination of blood-brain barrier penetration of phenols.
Stępnik KE; Malinowska I
J Chromatogr A; 2013 Apr; 1286():127-36. PubMed ID: 23506703
[TBL] [Abstract][Full Text] [Related]
16. Modeling Caco-2 permeability of drugs using immobilized artificial membrane chromatography and physicochemical descriptors.
Chan EC; Tan WL; Ho PC; Fang LJ
J Chromatogr A; 2005 Apr; 1072(2):159-68. PubMed ID: 15887485
[TBL] [Abstract][Full Text] [Related]
17. Insight into the retention mechanism on immobilized artificial membrane chromatography using two stationary phases.
Tsopelas F; Malaki N; Vallianatou T; Chrysanthakopoulos M; Vrakas D; Ochsenkühn-Petropoulou M; Tsantili-Kakoulidou A
J Chromatogr A; 2015 May; 1396():25-33. PubMed ID: 25911385
[TBL] [Abstract][Full Text] [Related]
18. Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: comparison with other lipophilicity measures.
Valko K; Du CM; Bevan CD; Reynolds DP; Abraham MH
J Pharm Sci; 2000 Aug; 89(8):1085-96. PubMed ID: 10906732
[TBL] [Abstract][Full Text] [Related]
19. Phospholipid-based Immobilized Artificial Membrane (IAM) Chromatography: A Powerful Tool to Model Drug Distribution Processes.
Sobanska AW; Brzezinska E
Curr Pharm Des; 2017; 23(44):6784-6794. PubMed ID: 29046146
[TBL] [Abstract][Full Text] [Related]
20. The use of immobilized artificial membrane chromatography to predict bioconcentration of pharmaceutical compounds.
Tsopelas F; Stergiopoulos C; Tsakanika LA; Ochsenkühn-Petropoulou M; Tsantili-Kakoulidou A
Ecotoxicol Environ Saf; 2017 May; 139():150-157. PubMed ID: 28130991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
